<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HFAF43EE744C34DF68E48A4383FE571C2" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 1432 IH: Let Injured Americans Be Legally Empowered Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-02-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1432</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250218">February 18, 2025</action-date><action-desc><sponsor name-id="R000614">Mr. Roy</sponsor> (for himself, <cosponsor name-id="M001184">Mr. Massie</cosponsor>, <cosponsor name-id="B001317">Mr. Brecheen</cosponsor>, <cosponsor name-id="C001115">Mr. Cloud</cosponsor>, <cosponsor name-id="H001077">Mr. Higgins of Louisiana</cosponsor>, <cosponsor name-id="C001132">Mr. Crane</cosponsor>, <cosponsor name-id="G000565">Mr. Gosar</cosponsor>, and <cosponsor name-id="P000605">Mr. Perry</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HJU00">Committee on the Judiciary</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To prohibit any Federal law from making the manufacturer of a COVID&#8211;19 vaccine immune from suit or liability, or limiting the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID&#8211;19 vaccine, and for other purposes.</official-title></form><legis-body id="H7725D4179D8943A6BF0636C28733A9E5" style="OLC"> 
<section id="HD4F10678C19B4F039E7216435CA34678" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Let Injured Americans Be Legally Empowered Act</short-title></quote> or the <quote><short-title>LIABLE Act</short-title></quote>.</text></section> <section id="H5F7A700C3B9C4705B13C26D61DEAF69C"><enum>2.</enum><header>No Federal immunity from, or limitation on, liability for manufacturers for loss caused by a COVID–19 vaccine</header> <subsection id="H55B5132305BE417682D83FA3BC04BDC0"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">No Federal law, including sections 319F–3, 2111, and 2122 of the Public Health Service Act (42 U.S.C. 247d–6d, 300aa–11, 300aa–22), may make the manufacturer of a COVID–19 vaccine immune from suit or liability, or limit the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID–19 vaccine.</text></subsection>
<subsection id="H9AC7CDFB08794A6E97EF1089F811D349"><enum>(b)</enum><header>Rule of construction</header><text display-inline="yes-display-inline">Nothing in this Act shall be construed to prohibit an individual from seeking compensation through the Countermeasures Injury Compensation Program under section 319F–4 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6e">42 U.S.C. 247d–6e</external-xref>) or the National Vaccine Injury Compensation Program under subtitle 2 of title XXI of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300aa-10">42 U.S.C. 300aa–10 et seq.</external-xref>).</text></subsection> <subsection id="HE1EF6F750FD04F9E82C9D4DE7117108F"><enum>(c)</enum><header>Relation to other programs</header><text display-inline="yes-display-inline">An individual shall not be precluded from bringing a civil action for claims described in subsection (a) on the basis of such individual having sought or received compensation through the Countermeasures Injury Compensation Program under section 319F–4 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6e">42 U.S.C. 247d–6e</external-xref>) or the National Vaccine Injury Compensation Program under subtitle 2 of title XXI of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300aa-10">42 U.S.C. 300aa–10 et seq.</external-xref>).</text></subsection>
<subsection id="H27D8E3024703408392E50094F22517C6"><enum>(d)</enum><header>Definition</header><text display-inline="yes-display-inline">The term <quote>COVID–19 vaccine</quote> means a vaccine licensed or otherwise authorized by the Food and Drug Administration to prevent, mitigate, or limit—</text> <paragraph id="HB5BBD7B4E8E34632A48049DDE228307F"><enum>(1)</enum><text>the harm from COVID–19; or</text></paragraph>
<paragraph id="H492AAA447DC44F599BBEE308DE9E00DA"><enum>(2)</enum><text>the transmission of SARS–CoV–2 or a virus mutating therefrom.</text></paragraph></subsection> <subsection id="H1350DF9DAF474314B6D4DFB20364A6BA"><enum>(e)</enum><header>Retroactive applicability</header><text>This Act applies without regard to whether the adminstration or use of a COVID–19 vaccine occurs before, on, or after the date of enactment of this Act.</text></subsection></section> 
</legis-body></bill>

